Aigen Investment Management, LP Axonics, Inc. Transaction History

Aigen Investment Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$49.38 - $63.75 $257,417 - $332,328	5,213 New	5,213 $324,000
Q2 2023 Aug 14, 2023	BUY	$47.99 - $60.21 $1.29 Million - $1.62 Million	26,959 New	26,959 $1.36 Million
Q4 2022 Feb 10, 2023	BUY	$59.56 - $76.6 $482,436 - $620,460	8,100 Added 224.31%	11,711 $732,000
Q3 2022 Nov 09, 2022	BUY	$57.96 - $78.12 $209,293 - $282,091	3,611 New	3,611 $254,000
Q4 2021 Feb 11, 2022	SELL	$50.01 - $73.35 $176,235 - $258,485	-3,524 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $208,656 - $277,197	3,524 New	3,524 $229,000
Q2 2020 Aug 10, 2020	SELL	$22.91 - $39.83 $11,729 - $20,392	-512 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$16.44 - $37.73 $8,417 - $19,317	512 New	512 $13,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Aigen Investment Management, LP, based on Form 13F filings with the SEC.

Stay updated on Aigen Investment Management, LP with notifications on news.